Athera (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B B2C (Retail)
Key People:
Carina Schmidt
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

Companies with similar profile to Athera:

CompanyCriteria
Sweden Scandinavian Real Hearts
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Denmark Antag Therapeutics
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Sweden Trialbee
46%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden OxThera
46%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden BoneSupport
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden Monocl
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Iceland Key Natura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Iconovo
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland Dispelix
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland WellO2
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Finland Desentum
44%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Oncology Venture
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Cytovation
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Bioservo Technologies
44%
  • Similar verticals: Health services
  • Similar business models: B2B, B2C (Retail)
  • Total raised in a similar range: 1M - 5M USD
Sweden Promimic
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 1M - 5M USD
Sweden Modus Therapeutics
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 1M - 5M USD
Sweden Airsonett
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden InDex Pharmaceuticals
35%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
Sweden AMRA
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden